🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study evaluates the addition of Amifostine to capecitabine and irinotec...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2018-05-28
Trial ID
NCT03702985
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as carboplatin, irinotecan, and...
Status
Completed
Location
University of Miami Sylvester Comprehensive Cancer Center
Start Date
2004-01
Trial ID
NCT00449020
Treatments Being Tested
The primary objective of this study is to evaluate the safety and efficacy ...
Status
Terminated
Location
University of Colorado Cancer Center
Start Date
2008-12
Trial ID
NCT00816777
Treatments Being Tested
The study evaluates the addition of Chinese Herbal Compound Dendrobium Huos...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2020-03-01
Trial ID
NCT04394598
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as irinotecan and cisplatin, wo...
Status
Completed
Location
Central Georgia Hematology Oncology Associates, P.C.
Start Date
2002-02
Trial ID
NCT00639769
Treatments Being Tested
The purpose of this study was to evaluate the efficacy and safety of tislel...
Status
Completed
Location
Henry Ford Hospital
Start Date
2018-01-26
Trial ID
NCT03430843
Treatments Being Tested
This is a three arm study to determine the maximum tolerated dose (MTD) of ...
Status
Completed
Location
Site Reference ID/Investigator# 37463
Start Date
2009-10
Trial ID
NCT01009073
Treatments Being Tested
The primary objective of this study is to evaluate the efficacy of Irinotec...
Status
Terminated
Location
Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden
Start Date
2010-02
Trial ID
NCT01060423
Treatments Being Tested
Significant activity (radiographic response rates of approximately 60%) has...
Status
Completed
Location
Århus Hospital
Start Date
2008-11
Trial ID
NCT00817284
Treatments Being Tested
Recruitment to phase I of the PANTHER trial is complete. Phase II, is to e...
Status
Completed
Location
Barts Health NHS Trust
Start Date
2014-05
Trial ID
NCT01862003
Treatments Being Tested